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Abstract The effect of metal ions on the activity,
the donor substrate specificity, and the stability in
organic solvents of Helicobacter pylori a-1,4 fuco-
syltransferase were studied. The recombinant enzyme
was expressed as soluble form in E. coli strain
AD494 and purified in a one step affinity chroma-
tography. Its activity was highest in cacodylate buffer
at pH 6.5 in the presence of 20 mM Mn2? ions
at 37C. Mn2? ions could be substituted by other
metal ions. In all cases, Mn2? ions proofed to be the
most effective (Mn2? [ Co2? [ Ca2? [ Mg2? [
Cu2? [ Ni2? [ EDTA). The enzyme shows sub-
strate specificity for Type I disaccharide (1) with a
KM of 114 lM. In addition, the H. pylori a-1,4
fucosyltransferase efficiently transfers GDP-activated
L-fucose derivatives to Galb1-3GlcNAc-OR (1).
Interestingly, the presence of organic solvents such
as DMSO and methanol up to 20% in the reaction
medium does not affect significantly the enzyme
activity. However, at the same concentration of
dioxane, activity is totally abolished.
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Abbreviations
BSA Bovine serum albumin
FucT Fucosyltransferase
GDP-L-fucose Guanosine 50-diphospho-b-
L-fucose
GDP-2-fluoro-L-fucose Guanosine 50-diphospho-2-
deoxy-fluoro-b-L-fucose
GDP-D-glucose Guanosine 50-diphospho-b-
D-glucose
GDP-L-arabinose Guanosine 50-diphospho-b-
L-arabinose
DMSO Dimethyl sulfoxide
Lem Lemieux spacer,
(CH2)8COOMe
Type I Galb-1,3GlcNAc-OR
Introduction
Mammalian glycosyltransferases catalyze the transfer
of glycosyl-residues from their activated glycosyl-
donors, usually sugar nucleotides, to OH-groups of
acceptor molecules. Hundreds of glycosyltransferases
are known to be involved in the biosynthesis of the
oligosaccharide moieties of mammalian glycoproteins
and glycolipids (Davies et al. 2005). These transfer-
ases are broadly classified into two main families,
termed either ‘retaining’ or ‘inverting’, depending on
whether the anomeric configuration of the donor is
retained or inverted in the product glycoside.
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Fucosyltransferases (FucTs, EC 2.4.1.xy) belong
to the family of inverting enzymes transferring
L-fucose from guanosine 50-diphospho-b-L-fucose
(GDP-L-fucose) to oligosaccharide acceptors. They
are present in both prokaryotic and eukaryotic
organisms (for a recent review see Ma et al. 2006).
In bacteria, FucTs were identified in Salmonella
(McClelland et al. 2001), E. coli (Shao et al. 2003)
and Yersinia (Chain et al. 2004). In addition, the
genome of the pathogenic bacterium Helicobacter
pylori has been shown to encode several FucTs
(Tomb et al. 1997; Alm et al. 1999). In this organism
FucTs are involved in the synthesis of Lewis A, B, X
and Y blood group antigens (Chan et al. 1995; Martin
et al. 1997; Monteiro et al. 1998; Wang et al. 2000).
As constituents of membrane lipopolysaccharides,
these Lewis structures have been suggested to mimic
the antigens of the host cell and therefore permit the
bacterium to escape from the immune response
(Appelmelk et al. 1996; Monteiro et al. 1998).
Despite their involvement into the synthesis of
identical oligosaccharide structures, the alignments of
H. pylori FucTs and mammalian a-1,4 and a-1,3/4
FucT show only low sequence homology, which in
addition is restricted to short regions. One example is
the peptide motif YxFxLxFENSxxxxYxTEK which is
conserved in bovine (Oulmouden et al. 1997), chim-
panzee (Costache et al. 1997), and human a-1,3/4
FucTs (Kukowska-Latallo et al. 1990) as well as in
a-1,4 H. pylori FucT (Rabbani et al. 2005a). The short
conserved motif Asp-X-Asp (DXD) or Glu-X-Asp
(EXD) present in various mammalian glycosyltrans-
ferase families (Breton et al. 1998; Wiggins and
Munro 1998), was also found in H. pylori a-1,4 FucT
(Rabbani et al. 2005a) and in H. pylori a-1,3/4 FucT
(Horton et al. 2004). The DXD motif located in the
catalytic site is essential for the enzyme activity,
because it can stabilize a divalent metal ion, which on
its part interacts with the diphosphate in GDP-L-
fucose (U¨nligil et al. 2000; Gastinel et al. 2001). This
is in contrast to H. pylori a-1,3 FucT, where the
interaction with the phosphates of GDP-fucose is
established by a direct contact with positively charged
amino acid side chains of Arg195 and Lys250
(Sun et al. 2007), redundantizing the DXD or EXD
motives.
Human FucTIII and FucTVI have been shown to
also accept non-natural donors allowing the synthesis
of oligosaccharide libraries with various acceptor
substrates as well as modified fucose-donors (Oehr-
lein 1999 and references therein). In the past, we have
already reported the acceptor substrate specificity of
H. pylori a-1,4 FucT (Rabbani et al. 2005a). In this
contribution, we investigated: (1) the requirements of
H. pylori a-1,4 FucT for metal ions, (2) its specificity
for various donor substrates and (3) the influence of
different organic solvents on its activity.
Experimental procedures
Materials
The H. pylori strain DMS6709 was isolated from
endoscopic biopsies at the University Hospital, Ga¨vle,
Sweden and deposited by Hoffmann-La Roche, Basel,
Switzerland at the Deutsche Sammlung von Mikroor-
ganismen, Braunschweig, Germany. E. coli AD494
strain has been purchased from Novagen. Ampicillin,
kanamycin and protein standard bovine serum albumin
(BSA) were obtained from Sigma. Type I acceptor
substrates (1) and (2) (Fig. 4) have been chemically
synthesized as described (Lemieux et al. 1975; Rab-
bani et al. 2005b). GDP-L-fucose (3) was a gift from
Yamasa Corp., GDP-2-deoxy-2-fluoro-L-fucose (4),
GDP-L-glucose (5) and GDP-D-arabinose (6) (Fig. 4)
were synthesized as described (Baisch and Ohrlein
1997). GDP-L-[14C]fucose (287 mCi/mmol) was pur-
chased from Amersham Biosciences.
Expression, purification and activity assay
Expression and purification of H. pylori a-1,4 FucT
were performed as described previously (Rabbani
et al. 2005a). For the evaluation of metal ions effect,
the effect of pH and organic solvents, GDP-L-
[14C]fucose was used as donor substrate. After
incubation, the reaction mixture was loaded onto a
sep-Pak-C18 cartridge (Waters). The cartridge was
washed twice with 5 ml bidistilled water and eluted
with 5 ml methanol. The enzyme activity was
calculated as percentage of [14C]fucose transferred
onto the acceptor substrate 1 as determined by liquid
scintillation counting. For the evaluation of the donor
substrate specificity, the fluorescent-labeled Type I
acceptor substrate 2 was employed and the fucosy-
lated product was quantified by RP-HPLC analysis
(see below).
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HPLC analysis
For the determination of the transfer efficiency of
GDP-L-fucose (3), GDP-2-deoxy-2-fluoro-L-fucose (4),
GDP-L-glucose (5) and GDP-D-arabinose (6) the fluo-
rescent-labeled Type I acceptor substrate 2 was used.
The isolation of the product was performed on a C18-RP
column (Nova-Pak C18, 60 A˚, 3.9 9 150 mm) attached
to a Spectra Physics HPLC system (Waters) and the
signal was monitored at 245 nm. A linear gradient using
water (A) and methanol (B) at a flow rate of1 ml/min and
at RT was run as follow: 0–5 min, 100% A; 5–10 min,
50% A; 10–25 min 25% A; 25–30 min, 100% B.
Effect of metal ions on H. pylori a-1,4 FucT
The effect of metal ions was investigated by using
MgCl2, CaCl2, MnCl2, CoCl2, NiCl2, CuCl2 and
ZnCl2 at a final concentration of 20 mM in cacodyl-
ate buffer pH 6.5. The enzyme activity was assayed
in the presence of 0.150 mM GDP-L-fucose (3) and
2 mM Type I acceptor 1 (saturating donor and
acceptor substrate concentrations). For the measure-
ment of the enzyme activity in the absence of metal
ions, EDTA was added at 2 mM final concentration.
Determination of kinetic parameters
The KM values for Type I acceptor 1 in the presence
of different metal ions were determined using
0.150 mM of GDP-L-fucose (3) and different con-
centrations of the acceptor substrate 1 ranging from
0.05 to 2 mM. The KM values were determined from
Lineweaver-Burk plots.
pH stability of H. pylori a-1,4 FucT
The pH stability of the enzyme was measured in
cacodylate buffer at pH values ranging from 5 to 7.5
in the absence and in the presence of 20 mM MnCl2.
The enzyme activity assay was carried out as
described above using the Type I acceptor substrate
1 and GDP-L-fucose (3) as donor substrate.
Organic solvent stability of H. pylori a-1,4 FucT
The enzymatic activity was evaluated in cacodylate
buffer pH 6.5 containing 0.150 mM GDP-L-fucose
(3), 2 mM Type I acceptor 1 and various amounts of
DMSO, methanol or dioxane ranging from 0 to 60%
(V/V). The reaction mixtures were then incubated for
30 min at 37C and the enzyme activity quantified by
liquid scintillation counting as described above.
Results and discussion
Mammalian FucTs have been shown to be valuable
tools for the chemo-enzymatic synthesis of natural
and non-natural oligosaccharides (for reviews see
Oehrlein 1999; Koeller and Wong 2000; Ernst et al.
2000). The H. pylori FucTs so far identified (Ge et al.
1997; Wang et al. 1999; Rasko et al. 2000; Rabbani
et al. 2005a) exhibit similar catalytic properties and
therefore represent a competitive alternative to the
mammalian enzymes. For an efficient application in
the chemo-enzymatic synthesis of oligosaccharides, a
detailed characterization of the catalytic properties of
our H. pylori a-1,4 FucT would be highly beneficial.
We therefore investigated the effect of metal ions and
different organic solvents on its activity. Further-
more, the pH optimum and the specificity for various
unnatural donor substrates were determined.
Effect of manganese ions (Fig. 1)
The enzymatic activity of H. pylori a-1,4 FucT was
measured in the absence and in the presence of Mn2?
Fig. 1 Effect of manganese ions on H. pylori a-1,4 FucT. The
activity of the enzyme was assayed in the presence of Type I
acceptor substrate 1 (2 mM) and GDP-L-fucose 3 (0.150 mM)
and different Mn2? concentrations ranging from 5 lM to
50 mM. EDTA was used at 2 mM concentration. The relative
enzyme activity was calculated as a percentage of radioactivity
counted in the methanol fraction
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ions at concentrations ranging from 5 lM to 50 mM.
The in vitro enzyme activity was 5-fold increased at
the optimal Mn2? concentration of 20 mM. This is in
agreement with the results obtained for human FucTs.
Thus, human FucT III was reported to be activated
6-fold in the presence of 10 mM Mn2? (Palma et al.
2004), whereas the activity of human FucT VII was
increased even 12-fold in the presence of 25 mM
Mn2? (Shinoda et al. 1997). Interestingly, H. pylori
a-1,4 FucT retains a residual activity of approxi-
mately 20% after the addition of EDTA, indicating
that manganese ions are not an absolute requirement
for activity. This may be the result of a different
binding mode of the sugar nucleotide. Whereas in
human FucT V (a-1,3 FucT) Mn2? ions have been
shown to mediate the complex formation with GDP-
L-fucose (3) (Murray et al. 1996), H. pylori a-1,3
FucT binds the sugar nucleotide directly and without
participation of Mn2? ions (Sun et al. 2007). It has
been proposed that in this case the role of Mn2? ions
is to induce conformational changes leading to an
optimal positioning of donor and acceptor substrates
in the catalytic site (Qasba et al. 2005).
Effect of alkaline ions, earth and transition
metal ions (Fig. 2, Table 1)
The effect of alkaline earth ions and transition metal
ions on the activity of H. pylori a-1,4 FucT was
studied in the presence of constant donor (0.150 mM)
and acceptor substrate (2 mM) concentrations. The
results indicate that H. pylori a-1,4 FucT can be
activated by several divalent ions in the order
Mn2?[ Co2?[ Ca2?[ Mg2?[Cu2?[ Ni2?[[ Zn2?.
Similarly to the homologous human FucT III (Palma
et al. 2004), FucT V (Murray et al. 1996), and FucT
VII (Shinoda et al. 1997), H. pylori a-1,4 FucT shows
a preference for metal ions that mostly adopt
octahedral coordination geometries. With Zn2?,
which prefers tetrahedral or quadratic pyramidal
coordinations, the activity of H. pylori a-1,4 FucT
disappeared. Furthermore, the KM for the substrate
acceptor Type I (1) was only slightly decreased when
Mn2? was substituted with Ca2? or Mg2?, however, a
substantial increase was observed with Co2?. In
summary, these results demonstrate the influence of
metal ions on the activity of H. pylori a-1,4 FucT and
that the substitution of paramagnetic Mn2? by other
metal ions such as Mg2? or Ca2? necessary for the
study of the enzymatic mechanism by NMR is
possible.
pH effect on FucT activity (Fig. 3)
In the presence of Mn2?, the H. pylori a-1,4 FucT
showed the highest activity at pH 6.5, whereas a
slight reduction was observed above and below this
pH value. Without Mn2? ions, the enzymatic activity
decreased by 70% at pH 5, by 90% at pH 6.5 and was
completely abolished at pH 7.5. Since GDP-L-fucose
(3) is stable between pH 5 and 8 (Nunez et al. 1981),
the observed reduction of product formation is not a
consequence of the hydrolysis of the fucosyl donor.
The observed pH dependence is comparable to
human FucTs as documented for example for FucT
III. In the presence of Mn2?, the highest activity was
observed between pH 6 and 8 and in the absence of
Fig. 2 Effect of alkaline earth and transition metal ions on
H. pylori a-1,4 FucT. The enzyme activity was assayed in the
presence of the indicated metal ions at 20 mM concentration.
EDTA was used at 2 mM concentration. The relative enzyme
activity was calculated as a percentage of radioactivity counted
in the methanol fraction
Table 1 Enzyme kinetic of the H. pylori a-1,4 FucT: The KM
for Type I acceptor substrate 1 in the presence of different
metal ions was determined using 0.150 mM of GDP-fucose
and Type I acceptor concentrations ranging from 0.05 to 2 mM
Metal ions KM [lM]
Mn2? 114
Co2? 169.3
Mg2? 126
Ca2? 116.5
The KM values were determined from Lineweaver-Burk plots
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Mn2?, the activity is significantly reduced at pH 5
and practically not existing at neutral and alkaline pH
values (Palma et al. 2004).
Donor substrate specificity (Fig. 4; Table 2)
For the examination of the donor substrate specificity
of H. pylori a-1,4 FucT, the sugar nucleotides GDP-2-
deoxy-2-fluoro-L-fucose (4), GDP-L-glucose (5), and
GDP-D-arabinose (6) were compared with GDP-L-
fucose (3). With the dansyl-derivative of Galb
(1-3)GlcNAc (2), which was used as acceptor sub-
strate, the quantification of the reaction products could
be conducted by RP-HPLC. The results indicate a
remarkable tolerance of the enzyme toward the
different sugar donors. GDP-2-deoxy-2-fluoro-L-
fucose (4), which has been shown to be a potent
competitive inhibitor of the human FucT V (Murray
et al. 1996), was transferred efficiently (79%) onto the
disaccharide acceptor (2). Less effective, but still
sufficient for a preparative application, GDP-L-glu-
cose (5) and GDP-D-arabinose (6) were transferred by
42 and 19%, respectively. Surprisingly, similar results
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Fig. 4 Structure of
acceptor 1, 2 and donor
substrates 3, 4, 5 and 6
Table 2 Donor substrate specificity of Helicobacter pylori
a-1,4 FucT: The fucosyltransferase assay was run in duplicate
(average values are shown) using the dansyl-Type I acceptor
substrate 2 at 2 mM concentration
Sugar nucleotides Relative activity [%]
GDP-L-fucose (3) 100
GDP-2-deoxy-2-fluoro-L-fucose (4) 79.8
GDP-L-glucose (5) 42.5
GDP-D-arabinose (6) 19.2
The product of the reaction was analyzed by RP-HPLC as
described in material and methods
Fig. 3 Effect of pH on the enzyme activity in the presence and
absence of Mn2? ions. The enzyme activity was evaluated at
different pH values in cacodylate buffer in the presence (j) of
20 mM Mn2? and in the absence (d) of Mn2?. The activity of
the enzyme was calculated as a percentage of radioactivity
counted in the methanol fraction
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have been reported for the human FucT III (Baisch
et al. 1997), since the two enzymes show a very low
sequence similarity. The tolerance of H. pylori a-1,4
FucT in respect to substrate donors qualifies this
bacterial enzyme for the preparation of non-natural
oligosaccharides.
Enzyme stability in organic solvents (Table 3)
For the evaluation of the stability of the enzyme
toward water miscible organic solvents the enzyme
activity was tested in aqueous dimethylsulfoxide
(DMSO), methanol and dioxane. With up to 20%
DMSO, the activity of the enzyme was only slightly
reduced, whereas higher DMSO proportions led to
enzyme inactivation. With a content of 20 and 30%
methanol, the enzyme activity was only slightly
reduced by 10 and 30%, respectively. Interestingly,
even at a content of 50% methanol, 11% of the
original activity was still sustained. In contrast, the
enzyme revealed a much higher sensitivity towards
dioxane. Already at 10% dioxane content the
activity was reduced by 50%. At 20%, it was
practically abolished. The reduced or abolished
catalytic activity could be caused by the loss of
critical water residues from the surface of the
enzyme leading to a drastic decrease in the polarity
of the enzymes microenvironment.
In summary, we report further biochemical char-
acterizations of H. pylori a-1,4 FucT. In the presence
of Mn2? ions, the enzyme activity is increased 5-fold.
Activation, however to a smaller extent, could also be
observed with other metal ions as Co2?, Ca2?, Cu2?.
Furthermore, the enzyme exhibits a remarkable
flexibility towards GDP-L-fucose derivatives. A sur-
prising tolerance towards organic solvents such as
DMSO and methanol could be demonstrated, whereas
already small amounts of dioxane abolish enzyme
activity. Finally, the properties of H. pylori a-1,4
FucT recommend its application for the preparative
synthesis of oligosaccharides and mimetics thereof.
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